August 22, 2018
Calyxt names biotech veteran and board of directors member Dr. Yves J. Ribeill as Interim CEO
August 10, 2018
Gene-editing startups ignite the next 'Frankenfood' fight (Reuters)
August 1, 2018
Calyxt reports financial results for second quarter and half-year 2018
July 19, 2018
Calyxt and S&W Seed Company announce milestone in alfalfa seed development program
June 27, 2018
Calyxt going boldly forward with a different bio-ag model (Seeking Alpha)
May 22, 2018
Calyxt announces successful closing of $60.9 million public offering
May 21, 2018
Calyxt announces full exercise of underwriters' option to purchase additional shares
May 18, 2018
Calyxt announces upsizing and pricing of follow-on offering
May 15, 2018
Calyxt announces launch of proposed follow-on offering
Bayer CropScience, LP agrees to settle lawsuit filed by Calyxt in Delaware Chancery Court
May 7, 2018
Calyxt reports financial results for first quarter 2018
April 5, 2018
Calyxt exceeds farmer adoption milestone for high-oleic soybean product launch
March 22, 2018
Calyxt's high fiber wheat deemed non-regulated by USDA - Calyxt's first consumer-centric wheat product, and seventh product overall, to receive this designation
March 13, 2018
Calyxt reports financial results for fourth quarter and full-year 2017
March 12, 2018
Calyxt files complaint in Delaware Chancery Court against Bayer CropScience, LP
March 1, 2018
Calyxt expands total acreage with farmers for high-oleic soybean product
December 12, 2017
Calyxt and Farmer's Business Network, Inc. partner to expand grower base for Calyxt's identity-preserved high oleic soybeans
November 13, 2017
Calyxt reports financial results for third quarter and first nine months of 2017
October 2, 2017
Calyxt and S&W Seed Company's gene-edited alfalfa plant designated as non-regulated by USDA - Improved qualify alfafa product candidate represents sixth product from Calyxt to be confirmed as non-regulated
September 25, 2017
Calyxt advances herbicide-tolerant wheat and improved oil composition canola product candidates to Phase 1 - Nine product candidates now in Phase 1 or higher across soybean, wheat, canola, potato and alfalfa crops
September 6, 2017
Calyxt to break ground on new concept-to-fork facility in Roseville, Minnesota
July 25, 2017
Calyxt announces full exercise of over-allotment option and closing of its initial public offering
July 19, 2017
Calyxt announces pricing of $56.0 million initial public offering
July 10, 2017
Calyxt announces proposed initial public offering of $100.0 million
June 7, 2017
Calyxt names Joseph B. Saluri as General Counsel & EVP, Corporate Development
May 17, 2017
Calyxt launches U.S. field trials with University of Minnesota for powdery mildew-resistant spring wheat variety - Wheat marks Calyxt’s fourth gene edited crop to undergo trials
May 10, 2017
Calyxt patent encompassing broad uses of plant gene editing technologies maintained by USPTO - U.S. patent 8,921,332 refers to the use of chimeric endonucleases, such as zinc finger nucleases, TAL-effector nucleases, mega-TALs and CRISPR/Cas9 to precisely edit DNA within plant genomes
March 21, 2017
Calyxt hires Cargill executive Manoj Sahoo as Chief Commercial Officer
March 10, 2017
Calyxt announces new technology framework agreement with Plant Bioscience Limited to expand IP portfolio
January 16, 2017
These foods aren’t genetically modified but they are ‘edited’ (The New York Times)
http://www.calyxt.com
Copyright @ 1992-2025 SeedQuest - All rights reserved